Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In June 2022, Bristol-Myers Squibb announced that it had inked a definitive merger agreement in order to acquire Turning Point Therapeutics with the objective of improving oncology medicines segment.

• In March 2022, AstraZeneca obtained clearance from the government of EU to sell Evusheld long-acting antibody combinations for preventing the incidence of Covid-19.

In the realm of pharmaceuticals and drug formulation, excipients play a pivotal role in ensuring the effectiveness, stability, and safety of medications. Segmented by product type, excipients encompass a diverse range of substances, each serving specific functions in the formulation process. Polymers, for instance, are commonly used as binders, disintegrants, and coating agents in oral solid dosage forms. Their versatility and compatibility with active pharmaceutical ingredients (APIs) make them indispensable in achieving desired drug release profiles and enhancing patient compliance.

Alcohols, such as ethanol and propylene glycol, find widespread use as solvents, preservatives, and viscosity modifiers in pharmaceutical formulations. They aid in solubilizing hydrophobic drugs, improving drug stability, and facilitating uniform distribution of APIs in liquid and semi-solid dosage forms. With careful consideration of safety and regulatory requirements, alcohols contribute to the efficacy and quality of pharmaceutical products across various therapeutic areas.

Minerals, including calcium carbonate, magnesium stearate, and silicon dioxide, serve as fillers, lubricants, and anti-caking agents in pharmaceutical formulations. These inert substances enhance tablet cohesion, facilitate tablet compression, and prevent powder adhesion during manufacturing processes. Minerals play a crucial role in ensuring the uniformity, integrity, and dissolution properties of oral solid dosage forms, thereby optimizing drug delivery and bioavailability.

Gelatin and sugar-based excipients, such as lactose, starch, and sucrose, are widely utilized as bulking agents, sweeteners, and flavoring agents in pharmaceutical formulations. They contribute to the palatability, stability, and aesthetic appeal of oral solid dosage forms, enhancing patient acceptance and adherence to medication regimens. Gelatin capsules provide an alternative to traditional tablet formulations, offering improved drug dissolution and bioavailability for certain APIs.

Beyond these primary excipient categories, the market encompasses a variety of other substances used in pharmaceutical formulations, including surfactants, antioxidants, and pH modifiers, among others. Each excipient serves a specific function in drug formulation, addressing challenges related to solubility, stability, and drug delivery.

Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Segment Analysis

In this report, the Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market has been segmented by Product, Application and Geography.

Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market, Segmentation by Product

The Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market has been segmented by Product into Polymers, Alcohols, Minerals, Gelatin and Sugar and Others.

Industrial applications represent the primary usage of pharmaceutical excipients in the formulation and production of oral solid dosage forms. Within this segment, excipients play crucial roles in drug development, manufacturing, and commercialization processes. They serve as essential components in the formulation of tablets, capsules, and powders, contributing to the stability, bioavailability, and patient acceptability of medications. Excipients are utilized as binders, disintegrants, fillers, lubricants, and coating agents, among other functionalities, to achieve desired drug release profiles, enhance manufacturing efficiency, and ensure product quality and consistency.

Non-industrial applications encompass a broad spectrum of activities related to research, development, quality control, and regulatory compliance in the pharmaceutical industry. Excipients are utilized in laboratory settings for formulation development, feasibility studies, and compatibility testing of drug substances. They play critical roles in pre-formulation studies, stability testing, and formulation optimization, helping pharmaceutical companies select the most appropriate excipients and dosage forms for drug candidates. Excipients are also employed in quality control assays and analytical testing methods to assess the identity, purity, and performance of pharmaceutical products, ensuring compliance with regulatory requirements and industry standards.

Excipients are utilized in non-traditional applications beyond drug formulation and manufacturing, including nutraceuticals, cosmeceuticals, and specialty chemical industries. In these sectors, excipients serve similar functions as in pharmaceutical applications, such as improving product stability, enhancing formulation aesthetics, and facilitating product manufacturing processes. Excipients play integral roles in delivering active ingredients, enhancing product performance, and ensuring consumer safety and satisfaction across diverse product categories.

Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market, Segmentation by Application

The Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market has been segmented by Application into Industrial Application and Non-industrial Application.

Industrial applications encompass the primary use of pharmaceutical excipients in the formulation, development, and manufacturing of oral solid dosage forms (OSDFs). Within this segment, excipients play critical roles in drug delivery and product development processes. They are utilized as key components in the formulation of tablets, capsules, powders, and granules, serving various functions such as binders, disintegrants, fillers, lubricants, and coating agents. Excipients contribute to the stability, bioavailability, and patient acceptability of medications, ensuring consistent drug release profiles, manufacturing efficiency, and product quality. Additionally, excipients are integral to the manufacturing processes of OSDFs, facilitating tablet compression, capsule filling, and coating operations. Excipients also play essential roles in ensuring compliance with regulatory requirements and industry standards, supporting the commercialization and distribution of pharmaceutical products worldwide.

Non-industrial applications encompass a wide range of activities related to research, development, quality control, and regulatory compliance in the pharmaceutical industry. Within this segment, excipients are utilized in laboratory settings for formulation development, feasibility studies, and compatibility testing of drug substances. Excipients play crucial roles in pre-formulation studies, stability testing, and formulation optimization, assisting pharmaceutical companies in selecting suitable excipients and dosage forms for drug candidates. Additionally, excipients are employed in quality control assays and analytical testing methods to evaluate the identity, purity, and performance of pharmaceutical products. Non-industrial applications extend beyond traditional drug formulation and manufacturing to include applications in nutraceuticals, cosmeceuticals, and specialty chemical industries. In these sectors, excipients serve similar functions as in pharmaceutical applications, supporting the delivery of active ingredients, enhancing product performance, and ensuring consumer safety and satisfaction.

Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market, Segmentation by Geography

In this report, the Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market Share (%), by Geographical Region, 2024

Europe is another significant market for OSDFs and pharma excipients, supported by factors such as a well-established pharmaceutical industry, strong regulatory framework, and increasing demand for generic drugs and over-the-counter medications. The region comprises diverse markets with varying levels of healthcare expenditure and consumption patterns. Key markets within Europe include the United Kingdom, Germany, France, Italy, and Spain, which are major contributors to the region's pharmaceutical market.

Latin America is an emerging market for OSDFs and pharma excipients, driven by factors such as improving healthcare infrastructure, rising disposable incomes, and growing awareness of healthcare issues. The region comprises diverse markets with varying levels of healthcare access and regulatory environments. Key markets within Latin America include Brazil, Mexico, Argentina, and Colombia, which are experiencing increasing demand for pharmaceutical products and services.

The Middle East and Africa represent a growing market for OSDFs and pharma excipients, supported by factors such as population growth, improving healthcare infrastructure, and increasing investment in healthcare services. The region offers opportunities for market expansion due to factors such as government initiatives to enhance healthcare access, rising prevalence of chronic diseases, and increasing adoption of generic drugs and over-the-counter medications. Key markets within the Middle East and Africa include Saudi Arabia, the United Arab Emirates, South Africa, and Nigeria.

This report provides an in depth analysis of various factors that impact the dynamics of Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers :

• Drug Formulation Innovation
• Rising Prevalence of Chronic Diseases
• Increasing Geriatric Population

• Growing Demand for Generic Drugs - The growing demand for generic drugs represents a significant trend in the global pharmaceutical industry, driven by various factors that are reshaping the healthcare landscape worldwide. Generic drugs are bioequivalent versions of brand-name medications that offer the same active ingredients, dosage forms, strengths, and routes of administration at a lower cost. This affordability, coupled with comparable efficacy and safety profiles, has fueled the adoption of generic drugs among patients, healthcare providers, and payers, contributing to their widespread acceptance and use across diverse therapeutic areas.

  One of the primary drivers of the growing demand for generic drugs is the increasing emphasis on cost containment and healthcare affordability. As healthcare expenditures continue to rise globally, governments, insurers, and healthcare providers are seeking ways to reduce healthcare costs without compromising patient access to essential medications. Generic drugs offer a cost-effective alternative to brand-name medications, providing significant savings for patients and healthcare systems while maintaining therapeutic effectiveness.

  Patent expirations of brand-name drugs have created opportunities for generic drug manufacturers to enter the market and offer affordable alternatives. When patents expire, generic manufacturers can produce bioequivalent versions of brand-name medications, leading to increased competition and lower prices. This competition incentivizes innovation, efficiency, and cost-saving measures within the pharmaceutical industry, ultimately benefiting patients and healthcare systems.

Restraints :

• Stringent Regulatory Requirements
• High Development Costs
• Limited Patent Exclusivity

• Drug Formulation Complexity - Drug formulation complexity refers to the intricate and multifaceted nature of developing pharmaceutical products that meet stringent requirements for efficacy, safety, stability, and patient acceptability. As pharmaceutical research advances and therapeutic targets become more sophisticated, drug formulation has become increasingly complex, presenting challenges and opportunities for drug developers, formulators, and manufacturers.

  One aspect of drug formulation complexity lies in the diverse range of drug molecules and therapeutic modalities being developed, including small molecules, biologics, peptides, and nucleic acid-based therapeutics. Each drug molecule presents unique physicochemical properties, stability considerations, and formulation requirements that must be carefully addressed during the formulation process. Formulating drugs with complex chemical structures, poor solubility, or instability poses challenges in achieving optimal drug delivery and therapeutic outcomes.

  The development of novel drug delivery systems and dosage forms adds to the complexity of drug formulation. Drug delivery technologies such as nanoparticles, liposomes, micelles, and implants enable targeted drug delivery, sustained release, and improved bioavailability of therapeutic agents. However, designing and optimizing these advanced delivery systems require expertise in material science, pharmacokinetics, and formulation engineering, as well as thorough characterization and evaluation to ensure safety and efficacy.

Opportunities :

• Emerging Markets Expansion
• Biopharmaceutical Excipients Development
• Personalized Medicine Trends

• Advanced Drug Delivery Systems - Advanced drug delivery systems represent a pivotal advancement in the field of pharmaceuticals, revolutionizing the way medications are formulated, administered, and delivered to target sites within the body. These systems encompass a diverse range of technologies and formulations designed to optimize drug efficacy, improve patient compliance, and minimize adverse effects through precise control over drug release, targeting, and pharmacokinetics.

  One key aspect of advanced drug delivery systems is their ability to enhance the bioavailability and therapeutic efficacy of drugs, particularly those with poor solubility, stability, or absorption properties. Nanotechnology-based delivery systems, such as nanoparticles, liposomes, and micelles, enable the encapsulation of drug molecules within nanoscale carriers, enhancing their solubility, stability, and bioavailability while enabling targeted delivery to specific tissues or cells. By encapsulating drugs within protective carriers, advanced delivery systems can overcome biological barriers, prolong drug circulation times, and enhance drug accumulation at disease sites, thereby maximizing therapeutic outcomes.

  Advanced drug delivery systems offer precise control over drug release kinetics, enabling sustained, controlled, or triggered release of therapeutic agents over extended periods. Controlled release formulations, such as hydrogels, microspheres, and implants, provide sustained drug release profiles, minimizing fluctuations in drug plasma levels and reducing dosing frequency, thereby enhancing patient compliance and convenience. Additionally, stimuli-responsive delivery systems, such as pH-sensitive, temperature-sensitive, or enzyme-responsive formulations, enable triggered drug release in response to specific physiological cues or external stimuli, offering precise spatiotemporal control over drug delivery and minimizing off-target effects.

Key players in Global Oral Solid Dosage Forms (Osdf) And Pharma Excipients Market include :

• Archer Daniels Midland (ADM)
• BASF
• Dow Chemical Company
• ABITEC Corporation

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis